Futura Medical plc (AIM:FUM)
United Kingdom · Delayed Price · Currency is GBP · Price in GBX 0.2090
+0.0200 (10.58%)
Nov 6, 2026, 4:45 PM GMT
Futura Medical Market Cap
Futura Medical has a market cap or net worth of 3.1 million as of November 6, 2026. It is the 45,541st most valuable company in the world and the 1,036th biggest in the United Kingdom. Its market cap has decreased by 57.48% in one year.
Market Cap
3.10M
Enterprise Value
1.85M
Revenue
2.32M
Global Rank
Country Rank
#1,036 United Kingdom
PE Ratio
n/a
ChartMarket Cap Chart
Since July 22, 2003, Futura Medical's market cap has decreased from 29.74M to 3.10M, a decrease of -89.58%. That is a compound annual growth rate of -9.25%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 3.10M | -52.20% |
| Dec 31, 2025 | 6.48M | -93.26% |
| Dec 31, 2024 | 96.12M | 25.06% |
| Dec 29, 2023 | 76.86M | -47.89% |
| Dec 30, 2022 | 147.48M | 30.69% |
| Dec 31, 2021 | 112.85M | 201.27% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Palatin Technologies | 7.26M |
| Fusion Antibodies | 7.26M |
| CRISM Therapeutics | 6.73M |
| Solvonis Therapeutics | 6.30M |
| OptiBiotix Health | 5.68M |
| Cizzle Biotechnology Holdings | 4.76M |
| Theracryf | 4.70M |
| Nuformix | 2.65M |